Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Nanchang University

China · Asia-Pacific

#606World rank of 1,038
44.9ICI scoreout of 100
#87National rank, of 169 in China
#177Regional rank, of 343 in Asia-Pacific
731Verified industry works, 2021 to 2025
312Company groups worked with (119 on two or more works)

Nanchang University is ranked #606 of 1,038. Its strongest pillar is scale (69): a network of 119 company groups on two or more joint works. It is held back most by co-creation (18): 731 verified industry works against about 1,357 expected for its mix of fields; and by breadth (40): partners concentrated in a few research fields.

Research Collaboration Index 2026: #584 of 1,195, Silver standing · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
18

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 731 verified works against about 1,357 expected for its fields (0.54 times the expected rate).

Durability20% of the score
55

How much of its industry work sits in sustained partnerships with the same company group. 29 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
69

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 119 company groups on two or more joint works; 29 sustained partnerships.

Breadth20% of the score
40

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (44.9) is the weighted average of the four percentiles. Rank 606 of 1,038 overall; 87 of 169 in China; 177 of 343 in Asia-Pacific. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

2.4%of its 30,826 research works in 2021 to 2025 were co-authored with a verified company
0.54Industry co-authorship rate: 0.54 times what its mix of research fields would predict (731 verified works; about 1,357 expected)
29sustained partnerships: the same company group on five or more joint works in three or more of the five years

In China

87 of 169 ranked universities in China

  1. #85 Nanjing University of Science and Technology world #593, score 45.5
  2. #86 Yanshan University world #594, score 45.4
  3. #87 Nanchang University world #606, score 44.9
  4. #88 University of Shanghai for Science and Technology world #608, score 44.8
  5. #89 Qingdao University world #612, score 44.7

All ranked universities →   Asia-Pacific: 177 of 343 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Strongest sector positions

#109 of 295Clean Energy Transition54.5 verified works in the sector
#239 of 638Pharmaceuticals and Therapeutics162 verified works in the sector
#193 of 481Advanced Materials and Nanotechnology51 verified works in the sector
Pharmaceuticals and Therapeutics
162#239 of 638
Clean Energy Transition
54.5#109 of 295
Advanced Materials and Nanotechnology
51#193 of 481
Batteries and Energy Storage
25.5#82 of 126
Advanced Manufacturing and Industry 4.0
25#173 of 201
Built Environment and Infrastructure
22#188 of 215
Chemicals, Process and Resources
20#205 of 237
Climate, Environment and Sustainability
20not ranked
Biotechnology and Advanced Therapies
19under 20 works
Artificial Intelligence
18.5under 20 works
Medical Technology and Digital Health
13under 20 works
Agriculture and Food Technology
10.5under 20 works
Automotive and Mobility
10under 20 works
Next-Generation Communications
5under 20 works
Cybersecurity and Digital Trust
3.5under 20 works
Software, Cloud and Data
3under 20 works
Quantum Technologies
1.5under 20 works
Not in any of the 21 sectors
265counted in the overall index

466 of its 731 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Nanchang University co-authored verified work with 312 company groups, consortium papers aside: 119 of them on two or more works, and 29 as sustained partners.

The largest 12 of its 312 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
Jiangsu Hengrui MedicineChinaMedicine665 of 5
State Grid Corporation of ChinaSTATE-OWNEDChinaEngineering375 of 5
HUTCHMED (China) LimitedHong KongMedicine194 of 5
Junshi BiosciencesChinaMedicine164 of 5
Jiangxi CopperChinaEngineering14.55 of 5
PowerChinaSTATE-OWNEDChinaEngineering14.54 of 5
Jiangling Motors CorporationChinaEngineering13.54 of 5
PhilipsNetherlandsEngineering123 of 5
Qilu Pharmaceutical Co.ChinaMedicine124 of 5
SinopecSTATE-OWNEDChinaEngineering115 of 5
China Nerin EngineeringChinaEngineering115 of 5
BeiGeneChinaMedicine103 of 5

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Its most-cited verified works with 30 or fewer authors, leaving out guidelines and consensus statements. Citation counts are those of the open scholarly record at harvest. Each title links to the work.

Over time

Verified industry works by year

742021
1002022
1212023
1852024
2512025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

19 industry-partnered clinical trials

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

Examples:

  • NCT07153744 Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction with Shanghai Hutchison Pharmaceuticals Limited, 2025
  • NCT06936748 SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors with Qilu Pharmaceutical Co., Ltd., 2025
  • NCT06999031 A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma with Cells & Genes Biotech (Shanghai) Co.,Ltd, 2024
  • NCT04974138 China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT) with Shenzhen Ausa Pharmed Co.,Ltd, 2024
  • NCT04974151 China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype with Shenzhen Ausa Pharmed Co.,Ltd, 2024
  • NCT06010875 A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors with Chongqing Precision Biotech Co., Ltd, 2023

Evidence checked

908 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 569 of 1,477 candidate links were set aside.

Why links were set aside
  • 403 company name not written in the author's affiliation
  • 37 part of a university or public institute's own unit
  • 34 ordinary-word name without a company suffix
  • 33 not an industry organisation
  • 18 excluded after hand audit: Generic name matched from other company names
  • 6 a place or common word that failed its stricter rule
  • 38 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

GRP Partnership Intelligence Platform

Where Nanchang University's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Nanchang University ranks #584 of 1,195, with Silver standing. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.